Agree on the need for a major partner. Research academia tie-ups are good but we need someone who can pony-up some upfront money to jumpstart their trials.
Until that happens, risk of running out of money only to raise again is a major one. At the least need to show a strong early results (not preclinical) soon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.